Orix (IX) Current Deferred Revenue (2014 - 2015)
Orix (IX) posted Current Deferred Revenue of $11.8 billion for Q1 2015, down 11.54% on a QoQ basis from $13.3 billion in Q1 2014, and down 11.54% year-over-year from $13.3 billion in Q1 2014.
Powered by 
Analysis
Orix (IX) Current Deferred Revenue (2014 - 2015) Analysis & Trends
Orix has reported Current Deferred Revenue for 2 years, with the latest figure at $11.8 billion in Q1 2015.
- On a quarterly basis, Current Deferred Revenue fell 11.54% year-over-year to $11.8 billion in Q1 2015; TTM through Mar 2015 was $11.8 billion, a 11.54% decrease from a year earlier, with the FY2015 full-year figure at $12.9 billion, down 6.14% from the prior year.
- Current Deferred Revenue was $11.8 billion for Q1 2015 at Orix, down from $13.3 billion in the prior quarter.
- The five-year high for Current Deferred Revenue was $13.3 billion in Q1 2014, with the low at $11.8 billion in Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Orix | 44.18 Bn | 44.51 Bn | 4.68 Bn |
| 2 | Royalty Pharma | 33.59 Bn | 35.70 Bn | - |
| 3 | Royal Gold | 21.14 Bn | 21.00 Bn | 390.45 Mn |
| 4 | OR Royalties | 6.88 Bn | 6.81 Bn | 82.22 Mn |
| 5 | Encore Capital | 2.11 Bn | 1.93 Bn | 455.04 Mn |
| 6 | Atlanticus Holdings | 1.41 Bn | 851.50 Mn | 686.46 Mn |
| 7 | Jefferson Capital | 1.18 Bn | 1.16 Bn | - |
| 8 | Lufax Holding | 1.04 Bn | -1.23 Bn | - |
| 9 | Upbound | 998.67 Mn | 893.37 Mn | 594.84 Mn |
| 10 | Metalla Royalty & Streaming | 942.93 Mn | 931.86 Mn | 4.75 Mn |